Annual Drug Patent Expirations for SPIRIVA
Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for SPIRIVA.
This drug has thirteen patent family members in ten countries.
The generic ingredient in SPIRIVA is tiotropium bromide. Two suppliers are listed for this compound. Additional details are available on the tiotropium bromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
